Rhumbline Advisers Integra Lifesciences Holdings Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Rhumbline Advisers holds 207,660 shares of IART stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207,660
Previous 217,119 4.36%
Holding current value
$4.6 Million
Previous $6.33 Million 40.36%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$17.14 - $31.74 $162,127 - $300,228
-9,459 Reduced 4.36%
207,660 $3.77 Million
Q2 2024

Aug 01, 2024
BUY
$23.14 - $34.72 $407,911 - $612,044
17,628 Added 8.84%
217,119 $6.33 Million
Q1 2024

May 09, 2024
SELL
$33.4 - $45.2 $406,444 - $550,038
-12,169 Reduced 5.75%
199,491 $7.07 Million
Q4 2023

Feb 08, 2024
SELL
$34.21 - $44.59 $437,545 - $570,306
-12,790 Reduced 5.7%
211,660 $9.22 Million
Q3 2023

Nov 09, 2023
SELL
$37.8 - $45.97 $163,598 - $198,958
-4,328 Reduced 1.89%
224,450 $8.57 Million
Q2 2023

Aug 08, 2023
SELL
$37.95 - $58.98 $200,262 - $311,237
-5,277 Reduced 2.25%
228,778 $9.41 Million
Q1 2023

May 11, 2023
SELL
$52.61 - $60.49 $123,212 - $141,667
-2,342 Reduced 0.99%
234,055 $13.4 Million
Q4 2022

Feb 14, 2023
BUY
$42.17 - $58.6 $496,804 - $690,366
11,781 Added 5.24%
236,397 $13.3 Million
Q3 2022

Nov 10, 2022
BUY
$42.28 - $57.17 $360,394 - $487,317
8,524 Added 3.94%
224,616 $9.52 Million
Q2 2022

Aug 11, 2022
BUY
$53.86 - $66.52 $884,435 - $1.09 Million
16,421 Added 8.22%
216,092 $11.7 Million
Q1 2022

May 12, 2022
SELL
$62.86 - $69.24 $249,679 - $275,021
-3,972 Reduced 1.95%
199,671 $12.8 Million
Q4 2021

Feb 10, 2022
BUY
$62.47 - $73.25 $264,685 - $310,360
4,237 Added 2.12%
203,643 $13.6 Million
Q3 2021

Nov 12, 2021
SELL
$64.97 - $76.19 $287,297 - $336,912
-4,422 Reduced 2.17%
199,406 $13.7 Million
Q2 2021

Aug 05, 2021
SELL
$66.79 - $76.63 $167,642 - $192,341
-2,510 Reduced 1.22%
203,828 $13.9 Million
Q1 2021

May 06, 2021
SELL
$62.63 - $71.15 $142,357 - $161,723
-2,273 Reduced 1.09%
206,338 $14.3 Million
Q4 2020

Feb 10, 2021
BUY
$43.31 - $66.55 $78,910 - $121,254
1,822 Added 0.88%
208,611 $13.5 Million
Q3 2020

Nov 12, 2020
SELL
$43.33 - $51.72 $243,254 - $290,356
-5,614 Reduced 2.64%
206,789 $9.77 Million
Q2 2020

Aug 13, 2020
BUY
$41.42 - $55.57 $113,822 - $152,706
2,748 Added 1.31%
212,403 $9.98 Million
Q1 2020

May 06, 2020
BUY
$36.67 - $61.04 $621,666 - $1.03 Million
16,953 Added 8.8%
209,655 $9.37 Million
Q4 2019

Feb 05, 2020
SELL
$55.73 - $62.49 $21,901 - $24,558
-393 Reduced 0.2%
192,702 $11.2 Million
Q3 2019

Oct 23, 2019
SELL
$53.29 - $64.59 $75,618 - $91,653
-1,419 Reduced 0.73%
193,095 $11.6 Million
Q2 2019

Aug 14, 2019
SELL
$46.45 - $55.85 $576,351 - $692,986
-12,408 Reduced 6.0%
194,514 $10.9 Million
Q1 2019

May 01, 2019
BUY
$42.97 - $57.33 $6,101 - $8,140
142 Added 0.07%
206,922 $11.5 Million
Q4 2018

Jan 31, 2019
BUY
$42.62 - $64.51 $2.27 Million - $3.44 Million
53,258 Added 34.69%
206,780 $9.33 Million
Q3 2018

Nov 07, 2018
SELL
$57.63 - $65.87 $154,967 - $177,124
-2,689 Reduced 1.72%
153,522 $10.1 Million
Q2 2018

Aug 06, 2018
SELL
$54.05 - $67.23 $263,439 - $327,679
-4,874 Reduced 3.03%
156,211 $10.1 Million
Q1 2018

May 02, 2018
BUY
$46.55 - $57.38 $130,060 - $160,319
2,794 Added 1.77%
161,085 $8.91 Million
Q4 2017

Feb 09, 2018
BUY
$46.22 - $51.77 $1.03 Million - $1.15 Million
22,293 Added 16.39%
158,291 $7.58 Million
Q3 2017

Nov 06, 2017
BUY
$47.8 - $53.63 $6.5 Million - $7.29 Million
135,998
135,998 $6.87 Million

Others Institutions Holding IART

# of Institutions
241
Shares Held
75.3M
Call Options Held
585K
Put Options Held
21.3K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email